Medicine and Dentistry
Endometrial Cancer
100%
Hereditary Nonpolyposis Colorectal Cancer
100%
Neoplasm
90%
Ovarian Cancer
66%
Body Mass Index
57%
Fallopian Tube
50%
BRCA Mutation
44%
Malignant Neoplasm
43%
Immunohistochemistry
43%
Pelvis
41%
Recurrent Disease
41%
Uterine Tube Carcinoma
40%
Endometrium Carcinoma
33%
Oncoprotein
33%
Granulosa Cell Tumour
33%
Cancer Growth
33%
Cyclooxygenase 2
33%
Acetylsalicylic Acid
33%
Tumor Progression
33%
Epidermal Growth Factor Receptor
33%
Cervical Cancer
33%
Abagovomab
33%
Primary Peritoneal Cancer
33%
Brachytherapy
33%
Desmoplastic Small Round Cell Tumor
33%
NY ESO 1 Antigen
33%
Prevalence
33%
Carcinosarcoma
33%
Anodyne
33%
Odds Ratio
33%
COVID-19
33%
Cancer Syndrome
29%
Cancer
26%
Germline Mutation
24%
Carcinoma
18%
Formamide
16%
Benign Tumor
16%
Growth Stimulation
16%
Cancer Risk
16%
Underweight
16%
Pathologist
16%
Adenocarcinoma
16%
Hysterectomy
16%
Gene Mutation
16%
Obesity
16%
Family History
15%
Health Care
14%
Etiology of Ovarian Cancer
13%
Cancer Cell
13%
Trophoblastic Disease
13%
Keyphrases
Fallopian Tube
50%
Fallopian Tube Carcinoma
41%
Epithelial Ovarian Tumor
40%
Robot-assisted Surgery
33%
Mutation-negative
33%
HPV Oncoproteins
33%
Ovarian Cancer
33%
Prostate-derived Ets Factor
33%
Cervical Cancer Progression
33%
Legal Quality
33%
Curette
33%
Clinicopathologic Study
33%
Epithelial Ovarian Cancer
33%
Vaginal Brachytherapy
33%
Epithelial Ovarian Carcinoma
33%
6q25.1
33%
Paclitaxel Chemosensitivity
33%
Abagovomab
33%
Prognostic Indicator
33%
Palliative Care Model
33%
Medical-legal Partnership
33%
Primary Peritoneal Cancer
33%
B-cell Lymphoma 2 (Bcl-2)
33%
Custody Planning
33%
P16 Gene
33%
Borderline Epithelial Ovarian Tumor
33%
Chromosome 6q
33%
Deletion Mapping
33%
Borderline Ovarian Tumor
33%
Prophylactic Oophorectomy
33%
Desmoplastic Small Round Cell Tumor (DSRCT)
33%
Gemcitabine Chemotherapy
33%
Ovarian Involvement
33%
Double Primary
33%
Endometrial Explants
33%
Protein Kinase
33%
Black Coffee
33%
Passive Risk
33%
Active Smoking
33%
Mitotic Progression
33%
Serous Tumor
33%
Tea Consumption
33%
Endometrial Cancer Risk
33%
Cyclooxygenase-2 Expression
33%
Uterine Carcinosarcoma
33%
Cancer-testis Antigen
33%
Base Damage
33%
Coffee Consumption
33%
Tumor
26%
Minor children
22%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
66%
Ovary Cancer
66%
Neoplasm
63%
Endometrium Carcinoma
33%
B Cell Lymphoma
33%
Cancer Growth
33%
NY ESO 1 Antigen
33%
Paclitaxel
33%
Protein Kinases
33%
Epidermal Growth Factor Receptor
33%
Abagovomab
33%
Uterine Cervix Cancer
33%
Peritoneum Cancer
33%
Acetylsalicylic Acid
33%
Immunotherapy
33%
Oncoprotein
33%
Ovary Carcinoma
33%
Recurrent Disease
33%
Analgesic Agent
33%
Malignant Neoplasm
31%
Ovary Tumor
26%
Cystadenoma
25%
Obesity
15%
Underweight
14%
Trophoblastic Disease
13%
Enzyme-Linked Immunosorbent Assay
13%
Hydroxytamoxifen
12%
Adenocarcinoma
11%
Prospective Study
11%
Uterine Cervix Carcinoma
11%
Case-Control Study
10%
Buffalo
10%
Tubulin
10%
Peritoneum Metastasis
8%
Anovulation
8%
Tumor Antigen
6%
Amphiregulin
6%
Primary Tumor
6%
Breast Cancer
6%
Survival Time
6%
Cancer Testis Antigen
6%
Paracetamol
5%
Solid Malignant Neoplasm
5%
Benign Neoplasm
5%